SMTL ID : 9qek.1

Structure of Human ROS1 Kinase Domain Harboring the G2032R Solvent-front Mutation in Complex with Zidesamtinib (NVL-520)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.21 Å

Oligo State

homo-dimer

Ligands

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 8 residues within 4Å: Chain A: Y.231, P.232, A.233, H.234, Y.242, R.248, L.249, E.250 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:A.233, A:Y.242, A:Y.242, A:E.250 EDO.3: 8 residues within 4Å: Chain B: Y.231, P.232, A.233, H.234, Y.242, R.248, L.249, E.250 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:A.233, B:Y.242, B:Y.242, B:E.250

2 x 01: Zidesamtinib

01.2: 16 residues within 4Å: Chain A: L.20, G.21, V.28, E.30, A.47, L.95, E.96, L.97, M.98, R.101, D.102, R.152, N.153, L.155, G.170, D.171 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.28, A:L.95, A:R.101, A:L.155, A:L.155 Hydrogen bonds: A:E.96, A:M.98 Halogen bonds: A:N.153 01.4: 16 residues within 4Å: Chain B: L.20, G.21, V.28, E.30, A.47, L.95, E.96, L.97, M.98, R.101, D.102, R.152, N.153, L.155, G.170, D.171 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:V.28, B:L.95, B:R.101, B:L.155, B:L.155 Hydrogen bonds: B:E.96, B:M.98 Halogen bonds: B:N.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tangpeerachaikul, A. et al., Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations. Mol.Cancer Ther. (2025)

Release Date

2025-04-30

Peptides

Proto-oncogene tyrosine-protein kinase ROS: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Proto-oncogene tyrosine-protein kinase ROS